Attached files
file | filename |
---|---|
8-K - FORM 8-K - Pregis Holding II CORP | c63642e8vk.htm |
Exhibit 99.1
Press Release |
For Immediate Release
Contacts:
Keith LaVanway
847-597-9353
klavanway@pregis.com
Keith LaVanway
847-597-9353
klavanway@pregis.com
PREGIS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2010
FINANCIAL RESULTS
FINANCIAL RESULTS
Deerfield, IL, March 23, 2011 Pregis Corporation, a leading international manufacturer,
marketer, and supplier of protective packaging products and specialty packaging solutions, today
announced its 2010 fourth quarter and full year financial results.
For the fourth quarter of 2010, the Company generated net sales of $221.7 million, an increase of
4.3% versus net sales of $212.6 million in the fourth quarter of 2009. Excluding the impact of
unfavorable foreign currency translation, resulting from the U.S. dollar strengthening against the
euro and pound sterling on a year-over-year basis, and the sales associated with our acquisition of
IntelliPack, the quarters net sales were higher by 7.1% compared to the prior year quarter. This
sales increase was driven by increased volumes resulting from the Companys growth initiatives and
the impact of selling price increases implemented in 2010.
For the full year, 2010 net sales increased 9.0% to $873.2 million as compared to $801.2 in 2009.
Excluding the impact of unfavorable foreign currency translation, and the acquisition of
IntelliPack, 2010 net sales increased 9.8%, due to the impact of increased volumes resulting from
the Companys growth initiatives as well as the impact of economic recovery, along with the impact
of selling price increases implemented in 2010.
Gross margin as a percent of net sales was 21.3% in the fourth quarter of 2010, compared
to 22.2% in the fourth quarter of 2009. For the full year, gross margin as a percent
of net sales decreased to 21.6% for 2010 compared to 23.9% for 2009. The year-over-year decline
in gross margin as a percent of net sales was driven by increased key raw material costs, partially
offset by year-over-year selling price increases. Full year average resin costs in North America
and Europe, as measured by their respective indices, were 27% and 39% higher in 2010 as compared to
2009, respectively.
The
Company generated an operating loss of $2.6 million in the fourth quarter of 2010 which
compared with operating income of $2.5 million for the same quarter 2009. This decrease in
operating income was primarily a result of increased key raw material costs, higher restructuring
costs in our European operations as we continue to upgrade management and drive cost reduction
initiatives, as well as increased depreciation expense, partially offset by year-over-year selling
price increases and the impact of
1
higher sales volumes. Adjusted EBITDA, or Consolidated Cash Flow as defined by our indentures,
is a significant operating measure used by the Company to measure its operating performance and
liquidity. Adjusted EBITDA was $18.9 million in the fourth quarter of 2010 compared to $17.9
million for the same period in 2009. The higher year-over-year Adjusted EBITDA was primarily a
result of year-over-year selling price increases, the impact of higher sales volumes, and the
acquisition of IntelliPack, partially offset by increased key raw material costs.
Operating
income for the full year of 2010 was $2.8 million, compared to 2009 operating income of
$14.9 million. This decrease in operating income was primarily due to increased key raw material
costs, partially offset by the impact of higher sales volumes, the acquisition of IntelliPack, and
the year-over-year impact of selling price increases. Adjusted EBITDA for full year 2010 was
$76.7 million compared to $85.3 million for full year 2009. The lower year-over-year Adjusted EBITDA was
primarily a result of the same drivers impacting operating income as described above.
Commenting on the Companys results, Glenn Fischer, President and Chief Executive Officer, stated,
In the fourth quarter, we continued to drive our growth initiatives, particularly in inflatable
and foam-in-place systems. However, its positive impact was more than offset by significant
year-over-year increases in our key raw material costs, which were higher compared with the fourth
quarter 2009 by over 24% in North America and 30% in Europe based on their respective indices.
Higher key raw materials costs negatively impacted us by over $11 million in the fourth quarter and
almost $42 million for full year 2010.
Mr. Fischer continued, Consistent with the trends throughout 2010, resin costs continued to
increase in the fourth quarter in both North America and Europe and have continued to increase in
the first quarter of 2011 as well. We implemented selling price increases in North America in late
fourth quarter, and have implemented additional increases in the
first quarter of 2011 in North America
and Europe as well. Market support for these selling price increases remains mixed.
Segment Performance
Comments on segment net sales and EBITDA performance for the fourth quarter of 2010 is as follows:
| Net sales of the protective packaging segment increased by $10.7 million, or 8.0%. This increase was driven primarily by increased volumes resulting from the Companys growth initiatives and the IntelliPack acquisition, partially offset by unfavorable foreign currency translation. Excluding the unfavorable foreign currency translation and the IntelliPack acquisition, net sales for the fourth quarter 2010 increased 8.2%. | ||
| EBITDA of the protective packaging segment increased $4.1 million compared to the same quarter of 2009. This increase was primarily due to higher sales volumes, impact of selling price increases, and the IntelliPack acquisition, partially offset by increased key raw material costs. |
2
| Net sales of the specialty packaging segment decreased $1.7 million, or 2.1% compared to the same quarter 2009. This decrease was primarily driven by unfavorable foreign currency translation. Excluding the unfavorable foreign currency translation, net sales for the fourth quarter 2010 increased 5.2% year-over-year driven by higher volumes from the Companys growth initiatives and the impact of selling price increases. | ||
| EBITDA of the specialty packaging segment decreased $6.4 million primarily due to increased key raw material costs, higher bad debt expense, and unfavorable currency, partially offset by increased sales volumes. |
A summary of Adjusted EBITDA, a significant measure required by the Companys indentures and used
by the Company to measure its operating performance and liquidity, is presented in the supplemental
information at the end of this release.
New
Credit Facility:
On March 23, 2011, Pregis and its subsidiaries entered into a $75 million
ABL credit facility with Wells Fargo Capital Finance as Agent. The facility is subject to a borrowing base (including eligible
accounts receivable and inventory) and includes a $30 million UK facility. The facility also provides for future uncommitted
increases of its maximum amount, not to exceed $40 million. The facility matures on the earlier of March 22, 2016 and the date
that is 90 days prior to the maturity of the existing high yield notes of Pregis Corporation (as such notes may be refinanced prior
to such maturity date). The advances under the ABL credit facilities bear interest, at our option, equal to adjusted LIBOR, plus an
applicable margin, or a base rate, plus an applicable margin. The applicable margin for LIBOR loans ranges from 2.5% to 3%, depending
on our average quarterly excess availability. The applicable margin for the base rate loans is 100 basis points lower than the applicable
margin for the LIBOR loans.
Obligations under the US facility are guaranteed by Pregis and
substantially all of its US subsidiaries and are secured by a first priority security interest in substantially all of the
assets (other than certain excluded property) of Pregis and its US subsidiaries and by capital stock of substantially all of Pregis
US subsidiaries and 65% of voting stock (and 100% of the nonvoting stock) of its first-tier foreign subsidiaries. Obligations under
the UK facility are guaranteed by Pregis and substantially all of its foreign and domestic subsidiaries and are secured by substantially
all of the assets (other than certain excluded property) of Pregis and its foreign and domestic subsidiaries and by capital stock of
substantially all of Pregis foreign and domestic subsidiaries. The facility contains customary representations, warranties, covenants
and events of default, including monthly compliance with a springing
fixed charge coverage ratio of 1.1 to 1.0 if the excess availability of Pregis and its subsidiaries falls below a
certain level. The ABL credit facility is also subject to mandatory
prepayments out of certain asset sales, insurance,
and condemnation proceeds if the excess availability of Pregis and its subsidiaries falls below a certain level.
Conference Call:
The Company will conduct an investor conference call to review its 2010 fourth quarter results on
Thursday, March 24, 2011 at 11:00 a.m. ET (10:00 a.m. CT). The call can be accessed through the
following dial-in numbers: Domestic: 866-730-5762; International: 857-350-1586; Participant
Passcode: 79108653. A replay of the conference call will be available through April 4, 2011. The
replay may be accessed using the following dial-in information: Domestic: 888-286-8010;
International: 617-801-6888; Passcode: 96472951.
About Pregis:
Pregis Corporation is a leading global provider of innovative protective, flexible, and foodservice
packaging and hospital supply products. The specialty-packaging leader currently operates 46
facilities in 18 countries around the world. Pregis Corporation is a wholly owned subsidiary of
Pregis Holding II Corporation. For more information about Pregis, visit the Companys web site at
www.pregis.com.
Safe Harbor Statement:
This press release contains forward-looking statements within the meaning of Section 27A of the
Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. You can
generally identify forward-looking statements by the Companys use of forward-looking terminology
such as anticipate, believe, continue, could, estimate, expect, intend, may,
might, plan, potential, predict, seek, should, or will, or the negative thereof or
other variations thereon or comparable terminology. These forward-looking statements are only
predictions and involve known and unknown risks and uncertainties, many of which are beyond the
Companys control. For a discussion of key risk factors, please see the risk factors disclosed in
the Companys annual report, which is available on its website, www.pregis.com. These risks may
cause actual results, performance or achievements to differ materially from any future results,
performance or achievements expressed or implied by these forward-looking statements. Given these
risk and uncertainties, you are cautioned not to place undue reliance on such forward-looking
statements. The forward-looking statements included in this press release are made only as of the
date hereof. The Company undertakes no duty to update its forward-looking statements.
3
Pregis Holding II Corporation
Consolidated Balance Sheets
Unaudited
(dollars in thousands, except shares and per share data)
Consolidated Balance Sheets
Unaudited
(dollars in thousands, except shares and per share data)
December 31, | ||||||||
2010 | 2009 | |||||||
Assets |
||||||||
Current assets |
||||||||
Cash and cash equivalents |
$ | 47,845 | $ | 80,435 | ||||
Accounts receivable |
||||||||
Trade, net of allowances of $7,513 and $6,015 respectively |
118,836 | 120,812 | ||||||
Other |
18,573 | 12,035 | ||||||
Inventories, net |
88,975 | 81,024 | ||||||
Deferred income taxes |
3,699 | 5,079 | ||||||
Due from Pactiv |
1,161 | 1,169 | ||||||
Prepayments and other current assets |
9,131 | 7,929 | ||||||
Total current assets |
288,220 | 308,483 | ||||||
Property, plant and equipment, net |
198,260 | 226,882 | ||||||
Other assets |
||||||||
Goodwill |
139,795 | 126,250 | ||||||
Intangible assets, net |
53,642 | 38,054 | ||||||
Deferred financing costs, net |
4,816 | 8,092 | ||||||
Due from Pactiv, long-term |
8,168 | 8,429 | ||||||
Pension and related assets |
11,848 | 13,953 | ||||||
Restricted Cash |
3,501 | | ||||||
Other |
448 | 404 | ||||||
Total other assets |
222,218 | 195,182 | ||||||
Total assets |
$ | 708,698 | $ | 730,547 | ||||
Liabilities and stockholders equity |
||||||||
Current liabilities |
||||||||
Current portion of long-term debt |
$ | 46,363 | $ | 300 | ||||
Accounts payable |
101,266 | 78,708 | ||||||
Accrued income taxes |
2,971 | 5,236 | ||||||
Accrued payroll and benefits |
14,626 | 14,242 | ||||||
Accrued interest |
7,654 | 7,722 | ||||||
Other |
20,903 | 18,311 | ||||||
Total current liabilities |
193,783 | 124,219 | ||||||
Long-term debt |
442,908 | 502,534 | ||||||
Deferred income taxes |
16,029 | 19,721 | ||||||
Long-term income tax liabilities |
5,732 | 5,463 | ||||||
Pension and related liabilities |
4,149 | 4,451 | ||||||
Other |
19,566 | 15,367 | ||||||
Stockholders equity: |
||||||||
Common stock $0.01 par value; 1,000 shares authorized,
14,900.35 shares issued and outstanding at
December 31, 2010 and 2009 |
| | ||||||
Additional paid-in capital |
155,055 | 151,963 | ||||||
Accumulated deficit |
(119,400 | ) | (82,328 | ) | ||||
Accumulated other comprehensive loss |
(9,124 | ) | (10,843 | ) | ||||
Total stockholders equity |
26,531 | 58,792 | ||||||
Total liabilities and stockholders equity |
$ | 708,698 | $ | 730,547 | ||||
4
Pregis Holding II Corporation
Consolidated Statements of Operations
Unaudited
(dollars in thousands)
Consolidated Statements of Operations
Unaudited
(dollars in thousands)
Three Months Ended December 31, | Year ended December 31, | |||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||
Net Sales |
$ | 221,688 | $ | 212,630 | $ | 873,206 | $ | 801,224 | ||||||||
Operating costs and expenses: |
||||||||||||||||
Cost of sales, excluding
depreciation
and amortization |
174,359 | 165,371 | 684,498 | 609,515 | ||||||||||||
Selling, general and administrative |
33,900 | 33,989 | 130,057 | 117,048 | ||||||||||||
Depreciation and amortization |
12,149 | 9,400 | 46,454 | 44,783 | ||||||||||||
Goodwill impairment |
| | | | ||||||||||||
Other operating expense, net |
3,923 | 1,378 | 9,442 | 14,980 | ||||||||||||
Total operating costs and expenses |
224,331 | 210,138 | 870,451 | 786,326 | ||||||||||||
Operating income (loss) |
(2,643 | ) | 2,492 | 2,755 | 14,898 | |||||||||||
Interest expense |
12,872 | 14,532 | 48,364 | 42,604 | ||||||||||||
Interest income |
(82 | ) | (218 | ) | (254 | ) | (394 | ) | ||||||||
Foreign exchange loss (gain), net |
260 | (486 | ) | 642 | (6,303 | ) | ||||||||||
Loss before income taxes |
(15,693 | ) | (11,336 | ) | (45,997 | ) | (21,009 | ) | ||||||||
Income tax benefit |
(2,328 | ) | (4,012 | ) | (8,925 | ) | (2,999 | ) | ||||||||
Net loss |
$ | (13,365 | ) | $ | (7,324 | ) | $ | (37,072 | ) | $ | (18,010 | ) | ||||
5
Pregis Holding II Corporation Consolidated
Statement of Cash Flow
(dollars in thousands)
Statement of Cash Flow
(dollars in thousands)
Year ended December 31, | ||||||||
2010 | 2009 | |||||||
Operating activities |
||||||||
Net loss |
$ | (37,072 | ) | $ | (18,010 | ) | ||
Adjustments to reconcile net loss to
cash provided by operating activities: |
||||||||
Depreciation and amortization |
46,454 | 44,783 | ||||||
Deferred income taxes |
(10,013 | ) | (1,060 | ) | ||||
Unrealized foreign exchange loss (gain) |
1,008 | (6,126 | ) | |||||
Amortization of deferred financing costs |
3,472 | 5,247 | ||||||
Amortization of debt discount |
2,945 | 861 | ||||||
Loss (gain) on disposal of property, plant
and equipment |
1,601 | (270 | ) | |||||
Stock compensation expense |
3,092 | 1,353 | ||||||
Defined benefit pension plan expense (income) |
279 | (1,189 | ) | |||||
Trademark impairment |
| 194 | ||||||
Changes in operating assets and liabilities: |
||||||||
Accounts and other receivables, net |
(8,062 | ) | 7,283 | |||||
Due from Pactiv |
(135 | ) | 5,195 | |||||
Inventories, net |
(10,230 | ) | 9,153 | |||||
Prepayments and other current assets |
(1,233 | ) | 17 | |||||
Accounts payable |
24,430 | (2,944 | ) | |||||
Accrued taxes |
(1,532 | ) | (7,876 | ) | ||||
Accrued interest |
(132 | ) | 1,043 | |||||
Other current liabilities |
(426 | ) | (1,829 | ) | ||||
Pension and other |
(1,705 | ) | (10,208 | ) | ||||
Cash provided by operating activities |
12,741 | 25,617 | ||||||
Investing activities |
||||||||
Capital expenditures |
(31,033 | ) | (25,045 | ) | ||||
Proceeds from sale of assets |
1,517 | 1,766 | ||||||
Proceeds from sale and leaseback of property,
net of costs |
17,875 | 9,850 | ||||||
Acquisition of business, net of cash acquired |
(32,105 | ) | | |||||
Change in restricted cash |
(3,501 | ) | | |||||
Cash used in investing activities |
(47,247 | ) | (13,429 | ) | ||||
Financing activities |
||||||||
Proceeds from note issuance, net of discount |
| 172,173 | ||||||
Proceeds from revolving credit facility |
500 | 42,000 | ||||||
Repayment of term B1 & B2 notes |
| (176,991 | ) | |||||
Deferred financing costs |
| (6,466 | ) | |||||
Repayment of debt |
| (4,312 | ) | |||||
Proceeds from foreign lines of credit |
3,719 | | ||||||
Other, net |
(153 | ) | (269 | ) | ||||
Cash provided (used in) financing activities |
4,066 | 26,135 | ||||||
Effect of exchange rate changes on cash
and cash equivalents |
(2,150 | ) | 933 | |||||
Increase (decrease) in cash and cash equivalents |
(32,590 | ) | 39,256 | |||||
Cash and cash equivalents, beginning of period |
80,435 | 41,179 | ||||||
Cash and cash equivalents, end of period |
$ | 47,845 | $ | 80,435 | ||||
6
Pregis Holding II Corporation
Supplemental Information
(Unaudited)
Supplemental Information
(Unaudited)
Calculation of Adjusted EBITDA (Consolidated Cash Flow)
(unaudited) | Three Months Ended December 31, | |||||||
(dollars in thousands) | 2010 | 2009 | ||||||
Net loss of Pregis Holding II Corporation |
$ | (13,365 | ) | $ | (7,324 | ) | ||
Interest expense, net of interest income |
12,790 | 14,314 | ||||||
Income tax benefit |
(2,328 | ) | (4,012 | ) | ||||
Depreciation and amortization |
12,149 | 9,400 | ||||||
EBITDA |
9,246 | 12,378 | ||||||
Other non-cash charges (income): |
||||||||
Unrealized foreign currency transaction losses (gains), net |
316 | (573 | ) | |||||
Non-cash stock based compensation expense |
1,703 | 292 | ||||||
Non-cash asset impairment charge |
| 194 | ||||||
Net unusual or nonrecurring gains or losses: |
||||||||
Restructuring, severance and related expenses |
4,429 | 1,023 | ||||||
Other unusual or nonrecurring gains or losses |
2,730 | 4,126 | ||||||
Other adjustments: |
||||||||
Amounts paid pursuant to management agreement with Sponsor |
444 | 481 | ||||||
Adjusted EBITDA (Consolidated Cash Flow) |
$ | 18,868 | $ | 17,921 | ||||
Note to above:
EBITDA is defined as net income before interest expense, interest income, income tax expense,
depreciation and amortization. Adjusted EBITDA, referred to as Consolidated Cash Flow within the
context of the Companys indentures, is presented herein because it is a material element of the
fixed charge coverage ratio and secured indebtedness leverage ratio included in the Companys
indentures and is a significant operating measure used by the Company to measure its operating
performance and liquidity.
7
Pregis Holding II Corporation
Supplemental Information
(Unaudited)
Supplemental Information
(Unaudited)
Calculation of Adjusted EBITDA (Consolidated Cash Flow)
(unaudited) | Twelve Months Ended December 31, | |||||||
(dollars in thousands) | 2010 | 2009 | ||||||
Net loss of Pregis Holding II Corporation |
$ | (37,072 | ) | $ | (18,010 | ) | ||
Interest expense, net of interest income |
48,110 | 42,210 | ||||||
Income tax benefit |
(8,925 | ) | (2,999 | ) | ||||
Depreciation and amortization |
46,454 | 44,783 | ||||||
EBITDA |
48,567 | 65,984 | ||||||
Other non-cash charges (income): |
||||||||
Unrealized foreign currency transaction losses (gains), net |
$ | 1,008 | (6,125 | ) | ||||
Non-cash stock based compensation expense |
3,092 | 1,363 | ||||||
Non-cash asset impairment charge |
| (59 | ) | |||||
Loss on sale leaseback transaction |
1,837 | | ||||||
Net unusual or nonrecurring gains or losses: |
||||||||
Restructuring, severance and related expenses |
9,157 | 16,138 | ||||||
Other unusual or nonrecurring gains or losses |
10,022 | 6,013 | ||||||
Other adjustments: |
||||||||
Amounts paid pursuant to management agreement with Sponsor |
2,471 | 2,045 | ||||||
Pro forma adjusted EBITDA of acquired business |
531 | | ||||||
Adjusted EBITDA (Consolidated Cash Flow) |
$ | 76,685 | $ | 85,359 | ||||
Note to above:
EBITDA is defined as net income before interest expense, interest income, income tax expense,
depreciation and amortization. Adjusted EBITDA, referred to as Consolidated Cash Flow within the
context of the Companys indentures, is presented herein because it is a material element of the
fixed charge coverage ratio and secured indebtedness leverage ratio included in the Companys
indentures and is a significant operating measure used by the Company to measure its operating
performance and liquidity.
8
Pregis Holding II Corporation
Fourth Quarter 2010
Supplemental Information
(Unaudited)
(Amounts and percentage changes are approximations due to rounding.)
Fourth Quarter 2010
Supplemental Information
(Unaudited)
(Amounts and percentage changes are approximations due to rounding.)
Gross Margin Calculations
Three Months Ended December 31, | Year Ended December 31, | |||||||||||||||||||||||
(dollars in thousands) | 2010 | 2009 | Change | 2010 | 2009 | Change | ||||||||||||||||||
Net sales |
$ | 221,688 | $ | 212,630 | $ | 9,058 | $ | 873,206 | $ | 801,224 | $ | 71,982 | ||||||||||||
Cost of sales, excluding
depreciation and amortization |
(174,359 | ) | (165,371 | ) | (8,988 | ) | (684,498 | ) | (609,515 | ) | (74,983 | ) | ||||||||||||
Gross margin |
$ | 47,329 | $ | 47,259 | $ | 70 | $ | 188,708 | $ | 191,709 | $ | (3,001 | ) | |||||||||||
Gross margin, as a percent
of net sales |
21.3 | % | 22.2 | % | (0.9 | )% | 21.6 | % | 23.9 | % | (2.3 | )% | ||||||||||||
Net Sales by Segment
Change Attributable to the | ||||||||||||||||||||||||||||||||||||||||||||||||
Following Factors | ||||||||||||||||||||||||||||||||||||||||||||||||
Three months ended December 31, |
Price / | Currency | ||||||||||||||||||||||||||||||||||||||||||||||
2010 | 2009 | $ Change | % Change | Mix | Volume | Acquisitions | Translation | |||||||||||||||||||||||||||||||||||||||||
(dollars in thousands) | ||||||||||||||||||||||||||||||||||||||||||||||||
Segment: |
||||||||||||||||||||||||||||||||||||||||||||||||
Protective Packaging |
$ | 144,758 | $ | 134,037 | $ | 10,721 | 8.0 | % | $ | 5,166 | 3.9 | % | $ | 5,749 | 4.3 | % | $ | 4,993 | 3.7 | % | $ | (5,187 | ) | (3.9 | )% | |||||||||||||||||||||||
Specialty Packaging |
76,930 | 78,593 | (1,663 | ) | (2.1 | )% | 1,572 | 2.0 | % | 2,578 | 3.2 | % | | 0.0 | % | (5,813 | ) | (7.3 | )% | |||||||||||||||||||||||||||||
Total |
$ | 221,688 | $ | 212,630 | $ | 9,058 | 4.3 | % | $ | 6,738 | 3.2 | % | $ | 8,327 | 3.9 | % | $ | 4,993 | 2.4 | % | $ | (11,000 | ) | (5.2 | )% | |||||||||||||||||||||||
Change Attributable to the | ||||||||||||||||||||||||||||||||||||||||||||||||
Following Factors | ||||||||||||||||||||||||||||||||||||||||||||||||
Year ended December 31, |
Price / | Currency | ||||||||||||||||||||||||||||||||||||||||||||||
2010 | 2009 | $ Change | % Change | Mix | Volume | Acquisitions | Translation | |||||||||||||||||||||||||||||||||||||||||
(dollars in thousands) | ||||||||||||||||||||||||||||||||||||||||||||||||
Segment: |
||||||||||||||||||||||||||||||||||||||||||||||||
Protective Packaging |
$ | 559,683 | $ | 497,144 | $ | 62,539 | 12.6 | % | $ | 2,055 | 0.4 | % | $ | 53,522 | 10.8 | % | $ | 17,562 | 3.5 | % | $ | (10,600 | ) | (2.1 | )% | |||||||||||||||||||||||
Specialty Packaging |
313,523 | 304,080 | 9,443 | 3.1 | % | 2,808 | 0.9 | % | 20,208 | 6.6 | % | | 0.0 | % | (13,573 | ) | (4.5 | )% | ||||||||||||||||||||||||||||||
Total |
$ | 873,206 | $ | 801,224 | $ | 71,982 | 9.0 | % | $ | 4,863 | 0.6 | % | $ | 73,730 | 9.2 | % | $ | 17,562 | 2.2 | % | $ | (24,173 | ) | (3.0 | )% | |||||||||||||||||||||||
9
Pregis Holding II Corporation
Supplemental Information
(Unaudited)
(Amounts and percentage changes are approximations due to rounding.)
Supplemental Information
(Unaudited)
(Amounts and percentage changes are approximations due to rounding.)
EBITDA by Segment
Three Months Ended December 31, |
||||||||||||||||
2010 | 2009 | $ Change | % Change | |||||||||||||
(dollars in thousands) | ||||||||||||||||
Segment: |
||||||||||||||||
Protective Packaging |
$ | 14,497 | $ | 10,360 | $ | 4,137 | 39.9 | % | ||||||||
Specialty Packaging |
4,157 | 10,547 | (6,390 | ) | (60.6 | )% | ||||||||||
Total segment EBITDA |
$ | 18,654 | $ | 20,907 | $ | (2,253 | ) | (10.8 | )% | |||||||
Year Ended December 31, |
||||||||||||||||
2010 | 2009 | $ Change | % Change | |||||||||||||
(dollars in thousands) | ||||||||||||||||
Segment: |
||||||||||||||||
Protective Packaging |
$ | 47,824 | $ | 52,561 | $ | (4,737 | ) | (9.0 | )% | |||||||
Specialty Packaging |
31,232 | 41,339 | (10,107 | ) | (24.4 | )% | ||||||||||
Total segment EBITDA |
$ | 79,056 | $ | 93,900 | $ | (14,844 | ) | (15.8 | )% | |||||||
10